| Literature DB >> 35431299 |
Hiroyuki Kikuchi1, Masaki Machida1,2, Itaru Nakamura2, Reiko Saito3, Yuko Odagiri1, Noritoshi Fukushima1, Tomoko Takamiya1, Shiho Amagasa1, Keisuke Fukui4, Takako Kojima5, Hidehiro Watanabe2, Shigeru Inoue1.
Abstract
BACKGROUND: This longitudinal study aimed to investigate how psychological distress levels changed from early to middle phases of the new coronavirus (COVID-19) pandemic depending on the living arrangements of individuals.Entities:
Keywords: K6; living arrangement; novel coronavirus; psychological distress
Mesh:
Year: 2022 PMID: 35431299 PMCID: PMC9189317 DOI: 10.2188/jea.JE20210397
Source DB: PubMed Journal: J Epidemiol ISSN: 0917-5040 Impact factor: 3.809
Figure 1. Date of surveys with COVID-19 epidemic curve in Japan
Characteristics of study participants
|
| % | Living with others | Living alone |
| |||
|
|
| ||||||
|
| % |
| % | ||||
|
| 2,400 | 1,954 | 446 | ||||
| Gender | 0.046 | ||||||
| Men | 1,200 | 50.0% | 958 | 49.0% | 242 | 54.3% | |
| Women | 1,200 | 50.0% | 996 | 51.0% | 204 | 45.7% | |
| Age, years | <0.001 | ||||||
| 20–39 | 800 | 33.3% | 615 | 31.5% | 185 | 41.5% | |
| 40–64 | 1,019 | 42.5% | 839 | 42.9% | 180 | 40.4% | |
| ≥65 | 581 | 24.2% | 500 | 25.6% | 81 | 18.2% | |
| Working status | <0.001 | ||||||
| No | 885 | 36.9% | 780 | 39.9% | 105 | 23.5% | |
| Yes | 1,515 | 63.1% | 1,174 | 60.1% | 341 | 76.5% | |
| Residential area | <0.001 | ||||||
| Northern Kanto (Ibaraki, Tochigi, Gunma Prefectures) | 221 | 9.2% | 193 | 9.9% | 28 | 6.3% | |
| Saitama Prefecture | 385 | 16.0% | 326 | 16.7% | 59 | 13.2% | |
| Chiba Prefecture | 339 | 14.1% | 291 | 14.9% | 48 | 10.8% | |
| Tokyo Metropolis | 922 | 38.4% | 696 | 35.6% | 226 | 50.7% | |
| Kanagawa Prefecture | 533 | 22.2% | 448 | 22.9% | 85 | 19.1% | |
| Education, years | <0.001 | ||||||
| Junior or high school graduate (≤12 years) | 559 | 23.3% | 462 | 23.6% | 97 | 21.7% | |
| Junior college graduate (13–15 years) | 487 | 20.3% | 424 | 21.7% | 63 | 14.1% | |
| University graduate or above (≥16 years) | 1,258 | 52.4% | 978 | 50.1% | 280 | 62.8% | |
| Other | 96 | 4.0% | 90 | 4.6% | 6 | 1.3% | |
| Annual income, Japanese yen | <0.001 | ||||||
| <2 million | 1,044 | 43.5% | 918 | 47.0% | 126 | 28.3% | |
| 2 million–<4 million | 608 | 25.3% | 440 | 22.5% | 168 | 37.7% | |
| 4 million–<6 million | 353 | 14.7% | 253 | 12.9% | 100 | 22.4% | |
| ≥6 million | 327 | 13.6% | 275 | 14.1% | 52 | 11.7% | |
| Smoking status | 0.262 | ||||||
| Smoker | 340 | 14.2% | 266 | 13.6% | 74 | 16.6% | |
| Ex-smoker | 344 | 14.3% | 283 | 14.5% | 61 | 13.7% | |
| Non-smoker | 1,716 | 71.5% | 1,405 | 71.9% | 311 | 69.7% | |
| Alcohol consumption | 0.035 | ||||||
| None | 1,020 | 42.5% | 832 | 42.6% | 188 | 42.2% | |
| Seldom (1–4 days/week) | 872 | 36.3% | 691 | 35.4% | 181 | 40.6% | |
| Often (5–7 days/week) | 508 | 21.2% | 431 | 22.1% | 77 | 17.3% | |
| Walking time, mins/day | 0.809 | ||||||
| <30 | 1,207 | 50.3% | 984 | 50.4% | 223 | 50.0% | |
| 30–59 | 792 | 33.0% | 648 | 33.2% | 144 | 32.3% | |
| ≥60 | 401 | 16.7% | 322 | 16.5% | 79 | 17.7% | |
| Regular vaccinations | <0.001 | ||||||
| No | 1,315 | 54.8% | 1,037 | 53.1% | 278 | 62.3% | |
| Yes | 1,085 | 45.2% | 917 | 46.9% | 168 | 37.7% | |
| Comorbidities | |||||||
| Hypertension | 453 | 18.9% | 374 | 19.1% | 79 | 17.7% | 0.487 |
| Diabetes | 135 | 5.6% | 112 | 5.7% | 23 | 5.2% | 0.634 |
| Heart disease | 68 | 2.8% | 53 | 2.7% | 15 | 3.4% | 0.455 |
| Stroke | 25 | 1.0% | 19 | 1.0% | 6 | 1.3% | 0.883 |
| Respiratory disease | 104 | 4.3% | 86 | 4.4% | 18 | 4.0% | 0.732 |
| Kidney disease | 14 | 0.6% | 12 | 0.6% | 2 | 0.4% | 0.678 |
| Cancer | 51 | 2.1% | 47 | 2.4% | 4 | 0.9% | 0.046 |
P-value was calculated by chi-square test.
Figure 2. Adjusted means of K6 score according to living arrangements: mixed-effect linear regression results. K6, Kessler’s six-item psychological distress (The higher score indicates unfavourable distress state). * indicate statistically significant results in 5% significance levels, respectively. All mean values were adjusted by gender, age, residential area (prefecture), working status, personal annual income, education, smoking status, alcohol consumption, walking time, number of comorbidities (none, 1, 2+), and regular vaccination. Error bar indicate 95% confidence intervals.
The number of participants and proportions of SPD by survey phases
| Survey phase | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Phase 5 | Phase 6 | Phase 7 | Phase 8 | Phase 9 | ||
| Number of participants | 2,400 | 2,141 | 2,200 | 2,149 | 2,155 | 2,085 | 2,086 | 2,066 | 2,080 | ||
|
| |||||||||||
| Overall | Living with others |
| 1,954 | 1,745 | 1,790 | 1,744 | 1,754 | 1,698 | 1,690 | 1,680 | 1,694 |
| Prop of SPD (%) | 9.2% | 11.5% | 10.3% | 8.9% | 10.9% | 9.6% | 9.3% | 9.3% | 9.3% | ||
|
| |||||||||||
| Living alone |
| 446 | 396 | 410 | 405 | 401 | 387 | 396 | 386 | 386 | |
| Prop of SPD (%) | 11.0% | 13.1% | 11.7% | 12.8% | 15.2% | 15.8% | 14.4% | 13.0% | 13.7% | ||
|
| |||||||||||
| Men | Living with others |
| 958 | 866 | 887 | 871 | 871 | 835 | 837 | 832 | 839 |
| Prop of SPD (%) | 9.0% | 11.3% | 9.2% | 8.7% | 10.0% | 9.2% | 9.0% | 9.3% | 8.6% | ||
|
| |||||||||||
| Living alone |
| 242 | 221 | 224 | 225 | 223 | 211 | 218 | 214 | 218 | |
| Prop of SPD (%) | 13.2% | 14.5% | 14.3% | 14.2% | 17.5% | 16.6% | 14.7% | 13.6% | 14.7% | ||
|
| |||||||||||
| Women | Living with others |
| 996 | 879 | 903 | 873 | 883 | 863 | 853 | 848 | 855 |
| Prop of SPD (%) | 9.3% | 11.6% | 11.4% | 9.0% | 11.8% | 10.0% | 9.7% | 9.3% | 10.1% | ||
|
| |||||||||||
| Living alone |
| 204 | 175 | 186 | 180 | 178 | 176 | 178 | 172 | 168 | |
| Prop of SPD (%) | 8.3% | 11.4% | 8.6% | 11.1% | 12.4% | 14.8% | 14.0% | 12.2% | 12.5% | ||
|
| |||||||||||
| Younger age | Living with others |
| 615 | 552 | 547 | 521 | 529 | 501 | 496 | 498 | 493 |
| Prop of SPD (%) | 15.4% | 19.4% | 18.6% | 17.3% | 19.1% | 19.4% | 17.1% | 16.9% | 18.1% | ||
|
| |||||||||||
| Living alone |
| 185 | 157 | 163 | 160 | 159 | 152 | 156 | 148 | 150 | |
| Prop of SPD (%) | 17.3% | 16.6% | 11.7% | 15.0% | 18.9% | 21.1% | 17.9% | 14.2% | 16.7% | ||
|
| |||||||||||
| Middle age | Living with others |
| 839 | 751 | 775 | 763 | 769 | 751 | 746 | 745 | 746 |
| Prop of SPD (%) | 8.2% | 9.9% | 8.9% | 7.6% | 10.1% | 7.3% | 8.3% | 8.2% | 7.9% | ||
|
| |||||||||||
| Living alone |
| 180 | 167 | 172 | 170 | 169 | 164 | 165 | 168 | 164 | |
| Prop of SPD (%) | 7.8% | 13.2% | 14.0% | 15.3% | 15.4% | 15.9% | 15.8% | 15.5% | 14.6% | ||
|
| |||||||||||
| Older age | Living with others |
| 500 | 442 | 468 | 460 | 456 | 446 | 448 | 437 | 455 |
| Prop of SPD (%) | 3.0% | 4.3% | 3.0% | 1.5% | 2.6% | 2.5% | 2.5% | 2.5% | 2.2% | ||
|
| |||||||||||
| Living alone |
| 81 | 72 | 75 | 75 | 73 | 71 | 75 | 70 | 72 | |
| Prop of SPD (%) | 3.7% | 5.6% | 6.7% | 2.7% | 6.8% | 4.2% | 4.0% | 4.3% | 5.6% | ||
SPD, severe psychological distress defined a score of 13 or above in Kessler’s six-item psychological distress scale.
Adjusted odds ratios in developing severe psychological distress according to living arrangement: mixed-effect logistic regression results
| Overall | Stratified by gender | Stratified by working status | Stratified by age | |||||||||||||||||||||||||||||
|
|
|
| ||||||||||||||||||||||||||||||
| Men | Women | Not-working | Working | Younger age (20–39) | Middle age (40–64) | Older age (≥65) | ||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
| |||||||||||||||||||||||||
|
| OR | 95% CI |
|
| OR | 95% CI |
|
| OR | 95% CI |
|
| OR | 95% CI |
|
| OR | 95% CI |
|
| OR | 95% CI |
|
| OR | 95% CI |
|
| OR | 95% CI |
| |
| Living arrangement | ||||||||||||||||||||||||||||||||
| Living with others | 1,954 | 1.00 | 958 | 1.00 | 996 | 1.00 | 780 | 1.00 | 1,174 | 1.00 | 615 | 1.00 | 839 | 1.00 | 500 | 1.00 | ||||||||||||||||
| Living alone | 446 | 1.19 | (0.68–2.05) | 242 | 1.26 | (0.61–2.61) | 204 | 0.91 | (0.38–2.17) | 105 | 1.00 | (0.27–3.74) | 341 | 1.26 | (0.69–2.32) | 185 | 1.55 | (0.78–3.10) | 180 | 0.73 | (0.26–2.06) | 81 | 1.04 | (0.16–6.55) | ||||||||
| Survey phase | ||||||||||||||||||||||||||||||||
| Phase 1 | 2,400 | 1.00 | 1,200 | 1.00 | 1,200 | 1.00 | 885 | 1.00 | 1,515 | 1.00 | 800 | 1.00 | 1,019 | 1.00 | 581 | 1.00 | ||||||||||||||||
| Phase 2 | 2,141 |
|
| ** | 1,087 | 1.38 | (0.87–2.19) | 1,054 |
|
| * | 789 |
|
| * | 1,352 |
|
| + | 709 | 1.38 | (0.89–2.16) | 918 |
|
| * | 514 | 2.02 | (0.82–4.99) | |||
| Phase 3 | 2,200 |
|
| * | 1,111 | 1.11 | (0.70–1.77) | 1,089 |
|
| * | 812 |
|
| * | 1,388 | 1.18 | (0.80–1.74) | 710 | 1.56 | (1.01–2.42) | 947 | 1.30 | (0.80–2.13) | 543 | 0.99 | (0.38–2.55) | |||||
| Phase 4 | 2,149 | 0.92 | (0.66–1.27) | 1,096 | 0.85 | (0.52–1.38) | 1,053 | 0.97 | (0.63–1.50) | 787 | 1.10 | (0.64–1.89) | 1,362 | 0.83 | (0.56–1.25) | 681 | 1.11 | (0.70–1.75) | 933 | 0.87 | (0.53–1.46) | 535 | 0.40 | (0.13–1.27) | ||||||||
| Phase 5 | 2,155 |
|
| * | 1,094 | 1.21 | (0.76–1.93) | 1,061 |
|
| * | 794 | 1.38 | (0.81–2.35) | 1,361 | 1.53 | (1.04–2.23) | 688 |
|
| + | 938 |
|
| * | 529 | 0.91 | (0.34–2.45) | ||||
| Phase 6 | 2,085 | 1.12 | (0.81–1.54) | 1,046 | 0.98 | (0.60–1.59) | 1,039 | 1.23 | (0.80–1.89) | 773 | 1.27 | (0.74–2.18) | 1,312 | 1.05 | (0.70–1.56) | 653 |
|
| + | 915 | 0.86 | (0.51–1.45) | 517 | 0.80 | (0.29–2.23) | |||||||
| Phase 7 | 2,086 | 1.06 | (0.77–1.47) | 1,055 | 0.89 | (0.54–1.44) | 1,031 | 1.22 | (0.79–1.88) | 770 |
|
| + | 1,316 | 0.85 | (0.57–1.28) | 652 | 1.06 | (0.67–1.69) | 911 | 1.13 | (0.68–1.87) | 523 | 0.88 | (0.32–2.43) | |||||||
| Phase 8 | 2,066 | 1.07 | (0.77–1.47) | 1,046 | 1.05 | (0.65–1.69) | 1,020 | 1.07 | (0.69–1.66) | 763 | 1.32 | (0.77–2.27) | 1,303 | 0.95 | (0.64–1.43) | 646 | 1.09 | (0.69–1.72) | 913 | 1.12 | (0.68–1.86) | 507 | 0.86 | (0.31–2.39) | ||||||||
| Phase 9 | 2,080 | 1.18 | (0.85–1.62) | 1,057 | 0.91 | (0.56–1.48) | 1,023 | 1.43 | (0.93–2.19) | 766 | 1.02 | (0.58–1.78) | 1,314 | 1.25 | (0.85–1.85) | 643 | 1.41 | (0.90–2.21) | 910 | 1.07 | (0.65–1.79) | 527 | 0.71 | (0.25–2.00) | ||||||||
| Interaction term | ||||||||||||||||||||||||||||||||
| Living alone*Phase 1 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | ||||||||||||||||||||||||
| Living alone*Phase 2 | 0.95 | (0.49–1.83) | 0.86 | (0.36–2.08) | 1.20 | (0.43–3.39) | 0.85 | (0.17–4.30) | 1.02 | (0.49–2.13) | 0.66 | (0.27–1.58) | 1.91 | (0.60–6.08) | 1.23 | (0.13–11.77) | ||||||||||||||||
| Living alone*Phase 3 | 0.85 | (0.44–1.66) | 1.00 | (0.41–2.41) | 0.79 | (0.28–2.28) | 1.04 | (0.22–4.85) | 0.90 | (0.43–1.90) |
|
| * |
|
| + | 3.42 | (0.38–30.63) | ||||||||||||||
| Living alone*Phase 4 | 1.61 | (0.83–3.12) | 1.36 | (0.56–3.30) | 2.24 | (0.79–6.32) | 1.32 | (0.27–6.41) | 1.76 | (0.84–3.71) | 0.72 | (0.30–1.74) |
|
| ** | 1.83 | (0.13–25.68) | |||||||||||||||
| Living alone*Phase 5 | 1.46 | (0.77–2.77) | 1.63 | (0.69–3.84) | 1.47 | (0.53–4.03) | 2.68 | (0.60–11.94) | 1.25 | (0.60–2.56) | 0.89 | (0.38–2.09) |
|
| + | 4.56 | (0.50–41.87) | |||||||||||||||
| Living alone*Phase 6 |
|
| + | 1.58 | (0.65–3.82) |
|
| + | 1.17 | (0.24–5.68) |
|
| * | 0.96 | (0.41–2.26) |
|
| ** | 1.94 | (0.18–21.46) | ||||||||||||
| Living alone*Phase 7 |
|
| + | 1.45 | (0.59–3.54) |
|
| * | 1.20 | (0.25–5.68) |
|
| * | 1.18 | (0.49–2.82) |
|
| ** | 1.39 | (0.13–15.01) | ||||||||||||
| Living alone*Phase 8 | 1.38 | (0.71–2.69) | 1.04 | (0.42–2.54) | 2.16 | (0.77–6.05) | 1.15 | (0.24–5.62) | 1.52 | (0.72–3.23) | 0.67 | (0.27–1.66) |
|
| * | 1.45 | (0.13–15.79) | |||||||||||||||
| Living alone*Phase 9 | 1.38 | (0.71–2.69) | 1.35 | (0.55–3.28) | 1.74 | (0.62–4.89) | 1.99 | (0.41–9.52) | 1.24 | (0.59–2.59) | 0.66 | (0.27–1.60) |
|
| * | 3.93 | (0.39–39.46) | |||||||||||||||
CI, confidence interval; OR, odds ratio.
All OR were adjusted by gender, age, residential area (prefecture), working status, personal annual income, education, smoking status, alcohol consumption, walking time, comorbidities (none, 1, 2+), and regular vaccination. +, *, and ** indicate statistically significant results in 10%, 5%, and 1% significance levels, respectively.